Role of AORTIC in dealing with rising cancer rates in Africa

North American Vice president of AORTIC
Role of AORTIC in dealing with rising cancer rates in Africa ( North American Vice president of AORTIC )
1 May 2014

The relationship between obesity and cancer, and other dietary factors

Dr Walter C. Willett - Harvard School of Public Health, Boston, USA
The relationship between obesity and cancer, and other dietary factors ( Dr Walter C. Willett - Harvard School of Public Health, Boston, USA )
25 Apr 2014

Engineering of polymeric nanoparticles for medical applications

Dr Omid Farokhzad - Harvard Medical School, Boston, USA
Engineering of polymeric nanoparticles for medical applications ( Dr Omid Farokhzad - Harvard Medical School, Boston, USA )
14 Nov 2013

ecancermedicalscience Editor's Choice: Robotic surgery in oncology

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
ecancermedicalscience Editor's Choice: Robotic surgery in oncology ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
22 Oct 2013

Stem cell therapy for prevention of radiation-induced salivary gland toxicity

Dr Rob Coppes - University of Groningen, Netherlands
Stem cell therapy for prevention of radiation-induced salivary gland toxicity ( Dr Rob Coppes - University of Groningen, Netherlands )
7 Oct 2013

The 'Make Sense Campaign' for head and neck cancer awareness

Prof René Leemans - General Secretary of the European Head and Neck Society
The 'Make Sense Campaign' for head and neck cancer awareness ( Prof René Leemans - General Secretary of the European Head and Neck Society )
2 Oct 2013

Highlights of the ALATRO 2013 conference

Dr Luis Pinillos - ALATRO 2013 Vice-President, Lima, Peru
Highlights of the ALATRO 2013 conference ( Dr Luis Pinillos - ALATRO 2013 Vice-President, Lima, Peru )
15 Aug 2013

ECC 2013 Preview: Scientific programme highlights

Prof Vincenzo Valentini and Ian Banks
ECC 2013 Preview: Scientific programme highlights ( Prof Vincenzo Valentini and Ian Banks )
11 Jul 2013

Science behind phase I clinical trials: targeting tumour cell development pathways

Dr Gary K. Schwartz - Memorial Sloan-Kettering Cancer Center, New York, USA
Science behind phase I clinical trials: targeting tumour cell development pathways ( Dr Gary K. Schwartz - Memorial Sloan-Kettering Cancer Center, New York, USA )
6 Jun 2013

Sorafenib stalls growth of treatment-resistant differentiated thyroid cancer

Dr Marcia Brose - University of Pennsylvania, Philadelphia, USA
Sorafenib stalls growth of treatment-resistant differentiated thyroid cancer ( Dr Marcia Brose - University of Pennsylvania, Philadelphia, USA )
2 Jun 2013

Sorafenib stalls growth of treatment-resistant differentiated thyroid cancer

Dr Marcia Brose - Abramson Cancer Center, University of Pennsylvania, USA
Sorafenib stalls growth of treatment-resistant differentiated thyroid cancer ( Dr Marcia Brose - Abramson Cancer Center, University of Pennsylvania, USA )
2 Jun 2013

New MEK inhibitor selumetinib is the first effective drug for advanced melanoma of the eye

Dr Richard D. Carvajal - Memorial Sloan-Kettering Cancer Center, New York, USA
New MEK inhibitor selumetinib is the first effective drug for advanced melanoma of the eye ( Dr Richard D. Carvajal - Memorial Sloan-Kettering Cancer Center, New York, USA )
1 Jun 2013